Bringing Precision Medicine into COVID-19 ICUs

“Precision medicine” is a novel term in the world of medical terminology. It commonly refers to future approaches to addressing rare genetic illnesses or cancers using genomic databases. While using large volumes of data to diagnose and treat disease is highly applicable to these conditions, precision medicine might be closer to most of us than we realize. At the Johns Hopkins University School of Medicine and Bloomberg School of Public Health, a team of researchers led by Professors Scott Zeger and Matthew Robinson have put precision medicine to work against COVID-19 through their development of the Severe COVID-19 Adaptive Risk Predictor (SCARP).